4.5 Review

Recognition of Streptococcus pneumoniae by the innate immune system

期刊

CELLULAR MICROBIOLOGY
卷 14, 期 4, 页码 460-466

出版社

WILEY
DOI: 10.1111/j.1462-5822.2011.01746.x

关键词

-

资金

  1. International Max Planck Research School for Infectious Diseases and Immunology (UK)
  2. Deutsche Forschungsgemeinschaft [OP 86/7-1, SFB/TR84]

向作者/读者索取更多资源

Streptococcus pneumoniae is both a frequent colonizer of the upper respiratory tract and a leading cause of life-threatening infections such as pneumonia, meningitis and sepsis. The innate immune system is critical for the control of colonization and for defence during invasive disease. Initially, pneumococci are recognized by different sensors of the innate immune system called pattern recognition receptors (PRRs), which control most subsequent host defence pathways. These PRRs include the transmembrane Toll-like receptors (TLRs) as well as the cytosolic NOD-like receptors (NLRs) and DNA sensors. Recognition of S. pneumoniae by members of these PRR families regulates the production of inflammatory mediators that orchestrate the following immune response of infected as well as neighbouring non-infected cells, stimulates the recruitment of immune cells such as neutrophils and macrophages, and shapes the adaptive immunity. This review summarizes the current knowledge of the function of different PRRs in S. pneumoniae infection.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Biochemistry & Molecular Biology

Pseudomonas aeruginosa Triggered Exosomal Release of ADAM10 Mediates Proteolytic Cleavage in Trans

Ahmad Aljohmani, Bastian Opitz, Markus Bischoff, Daniela Yildiz

Summary: This study found that infection with Pseudomonas aeruginosa and Streptococcus pneumoniae stimulates the activation of ADAM10 in epithelial cells, leading to inflammatory cell recruitment and loss of barrier integrity. The activation is based on the toxin repertoire rather than the bacterial particle itself.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Editorial Material Biochemistry & Molecular Biology

TBK1's Role in Bacterial Pneumonia: Perhaps More than Macrophages and IFNs

Facundo Fiocca Vernengo, Bastian Opitz

AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2022)

Article Infectious Diseases

HIV, STI and renal function testing frequency and STI history among current users of self-funded HIV pre-exposure prophylaxis, a cross-sectional study, Germany, 2018 and 2019

Uwe Koppe, Janna Seifried, Ulrich Marcus, Stefan Albrecht, Klaus Jansen, Heiko Jessen, Barbara Gunsenheimer-Bartmeyer, Viviane Bremer

Summary: This study investigated self-reported testing frequencies for HIV, STI, and renal function among self-funded PrEP users in Germany. The findings revealed that many users obtained medical tests less frequently than recommended, which can lead to missed diagnoses. Factors associated with infrequent testing included not getting tested before starting PrEP, using PrEP from informal sources, and on-demand/intermittent PrEP use.

EUROSURVEILLANCE (2022)

Article Medicine, General & Internal

Effectiveness of Immune Checkpoint Inhibition vs Chemotherapy in Combination With Radiation Therapy Among Patients With Non-Small Cell Lung Cancer and Brain Metastasis Undergoing Neurosurgical Resection

David Wasilewski, Josefine Radke, Ran Xu, Matthias Raspe, Anna Trelinska-Finger, Tizian Rosenstock, Paul Poeser, Elisa Schumann, Judith Lindner, Frank Heppner, David Kaul, Norbert Suttorp, Peter Vajkoczy, Nikolaj Frost, Julia Onken

Summary: This study aimed to evaluate and compare the overall survival of patients with non-small cell lung cancer (NSCLC) brain metastasis resection treated with radiation therapy and immune checkpoint inhibitors (ICIs) versus radiation therapy and chemotherapy. The results showed that patients receiving radiation therapy and ICIs had significantly longer overall survival compared to those receiving radiation therapy and chemotherapy.

JAMA NETWORK OPEN (2022)

Article Respiratory System

Human lungs show limited permissiveness for SARS-CoV-2 due to scarce ACE2 levels but virus-induced expansion of inflammatory macrophages

Katja Hoenzke, Benedikt Obermayer, Christin Mache, Diana Fathykova, Mirjana Kessler, Simon Doekel, Emanuel Wyler, Morris Baumgardt, Anna Loewa, Karen Hoffmann, Patrick Graff, Jessica Schulze, Maren Mieth, Katharina Hellwig, Zeynep Demir, Barbara Biere, Linda Brunotte, Angeles Mecate-Zambrano, Judith Bushe, Melanie Dohmen, Christian Hinze, Sefer Elezkurtaj, Mario Toennies, Torsten T. Bauer, Stephan Eggeling, Hong-Linh Tran, Paul Schneider, Jens Neudecker, Jens C. Rueckert, Kai M. Schmidt-Ott, Jonas Busch, Frederick Klauschen, David Horst, Helena Radbruch, Josefine Radke, Frank Heppner, Victor M. Corman, Daniela Niemeyer, Marcel A. Mueller, Christine Goffinet, Ronja Mothes, Anna Pascual-Reguant, Anja Erika Hauser, Dieter Beule, Markus Landthaler, Stephan Ludwig, Norbert Suttorp, Martin Witzenrath, Achim D. Gruber, Christian Drosten, Leif-Erik Sander, Thorsten Wolff, Stefan Hippenstiel, Andreas C. Hocke

Summary: This study reveals that severe lung injury in COVID-19 may result from macrophage-triggered immune activation rather than direct viral damage to the alveolar compartment.

EUROPEAN RESPIRATORY JOURNAL (2022)

Article Multidisciplinary Sciences

A biomathematical model of atherosclerosis in mice

Sibylle Schirm, Arash Haghikia, Markus Brack, Peter Ahnert, Geraldine Nouailles, Norbert Suttorp, Markus Loeffler, Martin Witzenrath, Markus Scholz

Summary: Atherosclerosis is a leading cause of death worldwide, and biomathematical modeling can help develop and improve prevention and treatment approaches. This study presents a biomathematical model of murine atherosclerosis, which can predict the disease progression and treatment outcomes under different diet and treatment conditions. By translating known biological mechanisms into mathematical equations and fitting model parameters using experimental data, the model accurately simulates the dynamics of atherosclerotic lesions.

PLOS ONE (2022)

Article Infectious Diseases

Disease severity in hospitalized COVID-19 patients: comparing routine surveillance with cohort data from the LEOSS study in 2020 in Germany

Uwe Koppe, Julia Schilling, Melanie Stecher, Maria Madeleine Ruethrich, Adine Marquis, Michaela Diercke, Martina Haselberger, Carolin E. M. Koll, Michaela Niebank, Bettina Ruehe, Stefan Borgmann, Linus Grabenhenrich, Kerstin Hellwig, Lisa Pilgram, Christoph Spinner, Thomas Paerisch

Summary: This study investigated factors associated with severe COVID-19 and compared the representativeness of the dataset to the general population. The results showed that patients above 76 years old were less likely represented in the LEOSS dataset, and they also had lower mortality. Factors associated with severe COVID-19 in LEOSS included increasing age, male sex, prior stem cell transplantation, and an elevated C-reactive protein at the time of diagnosis.

BMC INFECTIOUS DISEASES (2023)

Letter Respiratory System

Cystic fibrosis transmembrane conductance regulator modulators attenuate platelet activation and aggregation in blood of healthy donors and COVID-19 patients

Erik Asmus, Weronika Karle, Markus C. Brack, Corey Wittig, Felix Behrens, Leander Reinshagen, Moritz Pfeiffer, Sabrina Schulz, Bertina Mandzimba-Maloko, Lasti Erfinanda, Paul L. Perret, Laura Michalick, Patrick J. Smeele, Endry H. T. Lim, Charissa E. van den Brom, Alexander B. A. Vonk, Toralf Kaiser, Norbert Suttorp, Stefan Hippenstiel, Leif E. Sander, Florian Kurth, Ursula Rauch, Ulf Landmesser, Arash Haghikia, Robert Preissner, Harm J. Bogaard, Martin Witzenrath, Wolfgang M. Kuebler, Robert Szulcek, Szandor Simmons

EUROPEAN RESPIRATORY JOURNAL (2023)

Article Infectious Diseases

AIDS in the era of antiretroviral therapy: Changes in incidence rates and predictors of AIDS among people living with HIV under clinical care in Germany, a cohort study 1999-2018

Annemarie Pantke, Christian Kollan, Barbara Gunsenheimer-Bartmeyer, Bjoern-Erik Ole Jensen, Christoph Stephan, Olaf Degen, Dirk Schuermann, Tobias Kurth, Viviane Bremer, Uwe Koppe

Summary: This study aimed to examine the incidence rates and predictive utility of established prognostic factors for the progression to AIDS among people living with HIV under clinical care. The study used data from two observational cohorts of people living with HIV in Germany and found that the rates of a first AIDS event have continuously declined, and health outcomes depend on CD4 count, viral load, and age but not on transmission mode.

HIV MEDICINE (2023)

Article Infectious Diseases

Surface proteome of plasma extracellular vesicles as mechanistic and clinical biomarkers for malaria

Anna Lena Jung, Malene Moller Jorgensen, Rikke Baek, Marie Artho, Kathrin Griss, Maria Han, Wilhelm Bertrams, Timm Greulich, Rembert Koczulla, Stefan Hippenstiel, Dominik Heider, Norbert Suttorp, Bernd Schmeck

Summary: Malaria is a life-threatening disease caused by Plasmodium parasites, mainly occurring in tropical and subtropical countries. Plasmodium falciparum is the most prevalent cause of malaria in Africa and responsible for most malaria-related deaths worldwide. This study found that certain proteins on plasma sEVs can differentiate between healthy individuals and malaria patients, suggesting their potential as predictive biomarkers.

INFECTION (2023)

Article Infectious Diseases

Cenicriviroc for the treatment of COVID-19: first interim results of a randomised, placebo-controlled, investigator-initiated, double-blind phase II trial

Florian Kurth, Elisa T. Helbig, Lena J. Lippert, Charlotte Thibeault, Gianluca Barbone, Marius A. Eckart, Martin Kluge, Tobias Puengel, Muenevver Demir, Robert Roehle, Theresa Keller, Christoph Ruwwe-Gloesenkamp, Martin Witzenrath, Norbert Suttorp, Christof von Kalle, Leif E. Sander, Christoph Jochum, Frank Tacke

Summary: This study presents human data on the use of a chemokine receptor inhibitor, Cenicriviroc (CVC), in patients with COVID-19. The results demonstrate the efficacy of CVC in treating moderate to severe COVID-19 and its inhibitory effect on CCR2 and CCR5. However, further research is needed to evaluate the efficacy and safety of this drug.

JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE (2023)

Article Cell Biology

MicroRNA-223 Dampens Pulmonary Inflammation during Pneumococcal Pneumonia

Cengiz Goekeri, Peter Pennitz, Wibke Groenewald, Ulrike Behrendt, Holger M. Kirsten, Christian Zobel, Sarah A. Berger, Gitta Heinz, Mir-Farzin Mashreghi, Sandra-Maria Wienhold, Kristina Dietert, Anca D. Dorhoi, Achim Gruber, Markus Scholz, Gernot Rohde, Norbert Suttorp, Geraldine CAPNETZ Study Grp, Martin Witzenrath, Geraldine Nouailles

Summary: This study aimed to investigate the role of microRNA-223 in orchestrating pulmonary inflammation during pneumococcal pneumonia. It was found that low levels of serum microRNA-223 correlated with increased disease severity in patients. In murine experiments, the absence of microRNA-223 led to increased neutrophilic influx into the lungs, resulting in aggravated histopathology and acute lung injury.
Article Medicine, General & Internal

Novel protein biomarkers for pneumonia and acute exacerbations in COPD: a pilot study

Anna Lena Jung, Maria Han, Kathrin Griss, Wilhelm Bertrams, Christoph Nell, Timm Greulich, Andreas Klemmer, Hendrik Pott, Dominik Heider, Claus F. Vogelmeier, Stefan Hippenstiel, Norbert Suttorp, Bernd Schmeck

Summary: This study analyzed the value of selected plasma markers in the differential diagnosis and severity grading of community-acquired pneumonia (CAP) and acute exacerbations of chronic obstructive pulmonary disease (AECOPD). The levels of certain markers were found to differ between CAP and AECOPD patients and healthy individuals. These markers can serve as biomarkers and provide information on differential diagnosis and disease severity.

FRONTIERS IN MEDICINE (2023)

Article Infectious Diseases

Pathogen spectrum of community acquired pneumonia in people living with HIV (PLWH) in the German CAPNETZ-Cohort

Benjamin Schleenvoigt, Juliane Ankert, Grit Barten-Neiner, Florian Voit, Norbert Suttorp, Christoph Boesecke, Christian Hoffmann, Daiana Stolz, Mathias Pletz, Gernot Rohde, Martin Witzenrath, Marcus Panning, Andreas Essig, Jan Rupp, Olaf Degen, Christoph Stephan, M. Dreher

Summary: The objective of this study was to identify the pathogen spectrum of community acquired pneumonia in people living with HIV (PLWH), and to compare it with a matched HIV negative group in order to reassess therapeutic strategies for PLWH. The study used various methods to identify pathogens, and found that pneumococci were the most common pathogen among both PLWH and controls. The mortality rate was higher for PLWH compared to controls.

INFECTION (2023)

Article Infectious Diseases

Analysis of acute COVID-19 including chronic morbidity: protocol for the deep phenotyping National Pandemic Cohort Network in Germany (NAPKON-HAP)

Fridolin Steinbeis, Charlotte Thibeault, Sarah Steinbrecher, Yvonne Ahlgrimm, Ira An Haack, Dietrich August, Beate Balzuweit, Carla Bellinghausen, Sarah Berger, Irina Chaplinskaya-Sobol, Oliver Cornely, Patrick Doeblin, Matthias Endres, Claudia Fink, Carsten Finke, Sandra Frank, Sabine Hanss, Tim Hartung, Johannes Christian Hellmuth, Susanne Herold, Peter Heuschmann, Jan Heyckendorf, Ralf Heyder, Stefan Hippenstiel, Wolfgang Hoffmann, Sebastian Ulrich Kelle, Philipp Knape, Philipp Koehler, Lucie Kretzler, David Manuel Leistner, Jasmin Lienau, Roberto Lorbeer, Bettina Lorenz-Depiereux, Constanze Dorothea Luettke, Knut Mai, Uta Merle, Lil Antonia Meyer-Arndt, Olga Miljukov, Maximilian Muenchhoff, Moritz Mueller-Plathe, Julia Neuhann, Hannelore Neuhauser, Alexandra Nieters, Christian Otte, Daniel Pape, Rafaela Maria Pinto, Christina Pley, Annett Pudszuhn, Philipp Reuken, Siegberg Rieg, Petra Ritter, Gernot Rohde, Maria Roennefarth, Michael Ruzicka, Jens Schaller, Anne Schmidt, Sein Schmidt, Verena Schwachmeyer, Georg Schwanitz, Werner Seeger, Dana Stahl, Nicole Stobaeus, Hans Christian Stubbe, Norbert Suttorp, Bettina Temmesfeld, Sylvia Thun, Paul Triller, Frederik Trinkmann, Istvan Vadasz, Heike Valentin, Maria Vehreschild, Christof von Kalle, Marie von Lilienfeld-Toal, Joachim Weber, Tobias Welte, Christian Wildberg, Robert Wizimirski, Saskia Zvork, Leif Erik Sander, Janne Vehreschild, Thomas Zoller, Florian Kurth, Martin Witzenrath

Summary: The NAPKON-HAP study is a multi-centered observational study aimed at providing comprehensive data and biospecimen collection for the investigation of the pathophysiology and pathology of COVID-19. It will contribute significant scientific insights and high-quality data to aid researchers in understanding the acute and long-term outcomes of the disease.

INFECTION (2023)

暂无数据